Results 61 to 69 of about 1,622 (69)

Detection of collagens by multispectral optoacoustic tomography as an imaging biomarker for Duchenne muscular dystrophy

Nature Medicine, 2019
Adrian P Regensburger, Jörg Jüngert, Teresa Gerhalter   +2 more
exaly  

Therapeutic developments for Duchenne muscular dystrophy

Nature Reviews Neurology, 2019
Ingrid E C Verhaart, Annemieke Aartsma-Rus   +1 more
exaly  

Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management

Lancet Neurology, The, 2018
David J Birnkrant, Carla M Bann, Benjamin A Alman   +2 more
exaly  

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

Lancet Neurology, The, 2010
David J Birnkrant, Laura E. Case, Paula R Clemens   +2 more
exaly  

Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice

Cell, 2010
Alessandra Sacco, Foteini Mourkioti, Scott L Delp   +2 more
exaly  

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

New England Journal of Medicine, 2017
Richard S Finkel, Eugenio Mercuri, Basil T Darras   +2 more
exaly  

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

New England Journal of Medicine, 2017
Richard Shell, Linda P Lowes, Lindsay N Alfano   +2 more
exaly  

AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial

Nature Medicine
Jerry Mendell, Francesco Muntoni, Craig M Mcdonald   +2 more
exaly  

Advances in Duchenne muscular dystrophy gene therapy

Nature Reviews Genetics, 2003
exaly